Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 717 Jul 31 – Oct 28, 2026
- Disclosed funding
- $110.7B 574 disclosed amounts
- Median round
- $25M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| W WajoCompany profile Wajo develops AI agents that help people complete everyday tasks such as bookings, shopping and service coordination. Wajo develops AI agents that help people complete everyday tasks such as bookings, shopping and service coordination. | Undisclosed | Undisclosed | AI | United States | Investors | |
 ApartmentIQCompany profile ApartmentIQ provides multifamily operators with market data, pricing tools and property-marketing automation. ApartmentIQ provides multifamily operators with market data, pricing tools and property-marketing automation. | $25M | Follow-on investmentGrowth | Proptech | United States | Investors | |
| SD Silicon DataCompany profile Provides independent GPU pricing benchmarks and market data for the AI compute economy Provides independent GPU pricing benchmarks and market data for the AI compute economy | $30.5M | Series A | Fintech | United States | Investors | |
| I InfinimmuneCompany profile Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease | $75M | Series A | Biotech | United States | Investors | |
| S SocteraCompany profile Builds power amplifiers extending range and reliability of radar and satellite systems Builds power amplifiers extending range and reliability of radar and satellite systems | $4M | Seed | Defense tech | United States | Investors | |
| EB Epicrispr BiotechnologiesCompany profile Develops programmable epigenetic medicines to treat genetic diseases like FSHD Develops programmable epigenetic medicines to treat genetic diseases like FSHD | $90M | Series CSeries C+ | Biotech | United States | Investors | |
 NaturalCompany profile Natural provides payment infrastructure that lets developers build AI agents capable of making transactions. Natural provides payment infrastructure that lets developers build AI agents capable of making transactions. | $30M | Series A | Fintech | United States | Investors | |
| IT InStore TechnologyCompany profile Provides managed retail technology infrastructure for independent grocers Provides managed retail technology infrastructure for independent grocers | Undisclosed | StrategicUndisclosed | Ecommerce | United States | Investors | |
| AB Aureka BiotechnologiesCompany profile Builds biological foundation models and closed-loop infrastructure for drug discovery Builds biological foundation models and closed-loop infrastructure for drug discovery | $100M | Series B | Biotech | United States | Investors | |
| W Makes a fabric spray that refreshes and de-wrinkles clothing between washes | $1.2M | Pre-SeedPre-seed | Consumer | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jul 31, 2026
- 1Y Combinator (YC)
Vera Health, BioStack, Tractian
55rounds3led - 2Andreessen Horowitz (a16z)
Hex, ASI, Eka Robotics
43rounds16led - 3Sequoia Capital
Hex, Warhound, Whop
24rounds7led - 4Khosla Ventures
Arda Industries, Tolan
24rounds6led - 5General Catalyst
Hyperbolic, Re:Build, Provision Labs
23rounds7led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.